Ani Pharmaceuticals reported $201.99M in Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Ani Pharmaceuticals ANIP:US $ 201.99M 2.72M
Aurora Cannabis Inc ACB:CN 406.78M 7.23M
Biodelivery Sciences International BDSI:US $ 58.72M 19.91M
Canopy Growth Corp WEED:CN C$ 1.53B 164.21M
Depomed DEPO:US $ 78.67M 0.31M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Emergent Biosolutions EBS:US $ 848.9M 5.1M
Endo International Ordinary Shares ENDP:US $ 8300.6M 3.52M
Flexion Therapeutics FLXN:US $ 250.5M 28.96M
Heron Therapeutics HRTX:US $ 149.03M 0.05M
Hikma Pharmaceutical HIK:LN 932M 0
Knight Therapeutics Inc GUD:CN C$ 40.52M 634K
Lannett LCI:US $ 596.98M 6.29M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 34243M 1526M
Omeros OMER:US $ 313.02M 433K
Perrigo Ordinary Shares PRGO:US $ 3550.3M 5.6M
Teva Pharmaceutical TEVA:IT 23.75B 1.39B
Teva Pharmaceutical Industries TEVA:US $ 23746M 1386M